Skip to Content

Pyridostigmine Bromide

UK matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cholinesterase inhibitor (parasympathomimetic agent, indirect acting)

Treatment of myasthenia gravis

Chemical Name

Pyridinium, 3-[[(dimetylamino)carbonyl]oxy]-1-metyl-, bromide

Foreign Names

  • Pyridostigmini Bromidum (Latin)
  • Pyridostigmin bromid (German)
  • Bromure de Pyridostigmine (French)
  • Bromuro de piridostigmina (Spanish)

Generic Names

  • Piridostigmina bromuro (OS: DCIT)
  • Pyridostigmine Bromide (OS: JAN, BAN)
  • Pyridostigminbromid (PH: Ph. Eur. 8)
  • Pyridostigmine (bromure de) (PH: Ph. Eur. 8)
  • Pyridostigmine Bromide (PH: BP 2016, JP XVI, Ph. Int. 4, USP 38)
  • Pyridostigmine bromide (PH: Ph. Eur. 8)
  • Pyridostigmini bromidum (PH: Ph. Eur. 8, Ph. Int. 4)

Brand Names

  • Amiasten
    AC Farma, Peru
  • Amygra
    Tabros, Pakistan
  • Antilon
    Yuan Chou, Taiwan
  • Astinon
    Samarth, Philippines
  • Kalymin
    Arzneimittelwerk Dresden, Lithuania; Klocke, Georgia; Merck, Bulgaria; Pliva, Latvia
  • Kalymin forte
    Temmler, Germany
  • Kalymin N
    Temmler, Germany; Teva Eesti, Estonia
  • Kalymin retard
    Temmler, Germany
  • Meshanon
    Hasan, Vietnam
  • Mestinon
    A. Menarini, Hong Kong; A. Menarini, Philippines; A. Menarini, Singapore; A. Menarini, Thailand; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; Grupo Farma, Colombia; ICN, Oman; ICN, Slovakia; ICN Polfa Rzeszow S.A., Serbia; Kyowa Yakuhin, Japan; Laboratorios Raffo, Chile; Legacy Pharmaceuticals, Serbia; Meda, Belgium; Meda, Denmark; Meda, Finland; Meda, France; Meda, Hungary; Meda, Ireland; Meda, Italy; Meda, Malta; Meda, Netherlands; Meda, Norway; Meda, Poland; Meda, Portugal; Meda, Romania; Meda, Sweden; Meda, Turkey; Meda Pharm, Austria; Meda Pharm, Greece; MEDA Pharma, Switzerland; MEDA Pharma, Germany; Meda Pharma Sau, Spain; Meda Pharmaceuticals, United Kingdom; Medcor, Netherlands; Menarini, Vietnam; Pharmalink, Taiwan; Roche, Egypt; Roche, Lebanon; Roemmers, Argentina; Transfarma Medica Indah, Indonesia; Valeant, Australia; Valeant, Brazil; Valeant, Costa Rica; Valeant, Dominican Republic; Valeant, Egypt; Valeant, Guatemala; Valeant, Honduras; Valeant, Indonesia; Valeant, Nicaragua; Valeant, New Zealand; Valeant, Panama; Valeant, Peru; Valeant, El Salvador; Valeant, United States; Valeant Pharmaceuticals International, Canada
  • Mestinon retard
    MEDA Pharma, Switzerland; MEDA Pharma, Germany
  • Mestinon-SR
    Valeant Pharmaceuticals International, Canada
  • Pirydostygminy bromek NRIM
    NRIM, Poland
  • Pyridostigmine
    Rafa, Israel
  • Pyridostigmine Bromide NRIM
    NRIM, Netherlands
  • Pyridostigmine Bromide-Sunve Pharm
    Sunve, China
  • Pyridostigmine Pharmacie Centrale des Armées
    Pharmacie Centrale des Armées, France
  • Pyrimine
    Sriprasit Pharma, Thailand
  • Pyrinon
    Hana, Philippines
  • Pystinon
    Alexandria Co., Egypt


BANBritish Approved Name
DCITDenominazione Comune Italiana
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.